Alliance Provides First-to-Market Systems to Manage Imaging Clinical Trials Worldwide
By MedImaging International staff writers Posted on 27 Mar 2012 |
Merge Healthcare (Chicago, IL, USA), a provider of enterprise imaging and interoperability solutions and clinical trials software, announced a partnership with AG Mednet (Boston, MA, USA), a global medical image collection and delivery service, to provide life sciences companies with a full range of tools to manage imaging clinical trials worldwide.
The solution incorporates AG Mednet’s image collection platform with Merge Healthcare’s clinical imaging management system (Merge CIMS) to enable higher quality images and data flow directly into Merge’s CIMS and electronic data capture (EDC) solutions. This integration marks the first time a turnkey system for imaging core labs and sponsors provides an end-to-end solution to assemble, de-identify, and provide complete submissions to trial repositories, resulting in substantial query reductions and increased submission quality.
“This alliance creates the first complete infrastructure and feature set required by both commercial and academic core labs to carry out all the necessary logistics in support of clinical trials,” said Dr. Jeffrey Popma, an associate professor of medicine at Harvard Medical School (Boston, MA, USA), and director, angiographic core laboratory, Beth Israel Deaconess Medical Center (Boston, MA, USA).
“The market has been asking for a best-in-class, flexible platform that provides collection, delivery, and trial management functions,” said Jeff Surges, CEO, Merge Healthcare. “We’re excited to offer this solution to the market, and to already have five studies underway with large pharma companies utilizing the combined Merge/AG Mednet platform.”
“Merge’s extensive experience with PACS [picture archiving and communication systems], specialized viewers and EDC systems is the perfect platform to receive high-quality images and transmittal form data from sites connected to AG Mednet’s network," said Abraham Gutman, president and CEO of AG Mednet.
Merge CIMS is the first automated data and imaging workflow solution that enables radiology experts, sponsors, and CROs to more efficiently execute the imaging portion of a clinical trial. In addition to providing real-time access to study imaging and data information, Merge CIMS provides improved data quality, study performance, and decision-making ability while integrating best-of-breed EDC, PACS, image analysis, and image transport technologies. Generally, the integration of imaging and clinical trials solutions provides key stakeholders with the advanced, efficient, and accurate tools they need to perform mission critical tasks.
Merge Healthcare is a provider of eClinical software and services that optimizes the clinical trial process for pharmaceutical, biotechnology, medical device, and contract research organizations. Merge has facilitated over 1,800 trials involving more than 1 million patients in 80 countries, and has participated in 42 studies used for 14 new drug applications.
AG Mednet, which provides the largest HIPAA (Health Insurance Portability and Accountability Act of 1996) and 21 CFR Part 11 /GxP-compliant image collection, de-identification, and delivery service, enhances the quality of image submissions and considerably reduces administrative queries in imaging trials. With over 10,000 registered users in 58 countries, AG Mednet’s de-identification and eCRF capabilities, combined with its global managed network enhances site protocol compliance while providing reporting for regulatory requirements.
Related Links:
Merge Healthcare
AG Mednet
The solution incorporates AG Mednet’s image collection platform with Merge Healthcare’s clinical imaging management system (Merge CIMS) to enable higher quality images and data flow directly into Merge’s CIMS and electronic data capture (EDC) solutions. This integration marks the first time a turnkey system for imaging core labs and sponsors provides an end-to-end solution to assemble, de-identify, and provide complete submissions to trial repositories, resulting in substantial query reductions and increased submission quality.
“This alliance creates the first complete infrastructure and feature set required by both commercial and academic core labs to carry out all the necessary logistics in support of clinical trials,” said Dr. Jeffrey Popma, an associate professor of medicine at Harvard Medical School (Boston, MA, USA), and director, angiographic core laboratory, Beth Israel Deaconess Medical Center (Boston, MA, USA).
“The market has been asking for a best-in-class, flexible platform that provides collection, delivery, and trial management functions,” said Jeff Surges, CEO, Merge Healthcare. “We’re excited to offer this solution to the market, and to already have five studies underway with large pharma companies utilizing the combined Merge/AG Mednet platform.”
“Merge’s extensive experience with PACS [picture archiving and communication systems], specialized viewers and EDC systems is the perfect platform to receive high-quality images and transmittal form data from sites connected to AG Mednet’s network," said Abraham Gutman, president and CEO of AG Mednet.
Merge CIMS is the first automated data and imaging workflow solution that enables radiology experts, sponsors, and CROs to more efficiently execute the imaging portion of a clinical trial. In addition to providing real-time access to study imaging and data information, Merge CIMS provides improved data quality, study performance, and decision-making ability while integrating best-of-breed EDC, PACS, image analysis, and image transport technologies. Generally, the integration of imaging and clinical trials solutions provides key stakeholders with the advanced, efficient, and accurate tools they need to perform mission critical tasks.
Merge Healthcare is a provider of eClinical software and services that optimizes the clinical trial process for pharmaceutical, biotechnology, medical device, and contract research organizations. Merge has facilitated over 1,800 trials involving more than 1 million patients in 80 countries, and has participated in 42 studies used for 14 new drug applications.
AG Mednet, which provides the largest HIPAA (Health Insurance Portability and Accountability Act of 1996) and 21 CFR Part 11 /GxP-compliant image collection, de-identification, and delivery service, enhances the quality of image submissions and considerably reduces administrative queries in imaging trials. With over 10,000 registered users in 58 countries, AG Mednet’s de-identification and eCRF capabilities, combined with its global managed network enhances site protocol compliance while providing reporting for regulatory requirements.
Related Links:
Merge Healthcare
AG Mednet
Latest Imaging IT News
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
- Digital Pathology Software Improves Workflow Efficiency
- Patient-Centric Portal Facilitates Direct Imaging Access
- New Workstation Supports Customer-Driven Imaging Workflow
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more